Randomized Controlled Immunotherapy Clinical Trials for GBM Challenged
/in Dendritic Cells, Glioblastoma, Hyperthermia, International Publications, IOZK Veröffentlichungen, Newcastle Disease Virus /von 2020-12-24 / Cancers (Basel) 2020 Dec;13(1)Antitumor Activity of Curcumin in Glioblastoma
/in Curcuma, Glioblastoma, International Publications /von 2020-12-11 / Int J Mol Sci 2020 Dec;21(24)Das IOZK eröffnet die Corona Ambulanz Köln in der Infektiologie am IOZK
/in IOZK Aktuelles, IOZK In der Presse, IOZK Meldungen /von IOZKOncolytic effects of the recombinant Newcastle disease virus, rAF-IL12, against colon cancer cells in vitro and in tumor-challenged NCr-Foxn1nu nude mice
/in Colorectal Cancer, International Publications, Newcastle Disease Virus /von 2020-12-08 / PeerJ 2020;8:e9761Recent Advances in Hyperthermia Therapy-Based Synergistic Immunotherapy
/in Hyperthermia, International Publications /von 2020-12-02 / Adv Mater 2021 Jan;33(4):e2004788
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Das IOZK
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies
- Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrum
- Individualized Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical Experience from a Single Institution